Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team
Press release

Redeye: Nepa - Set to recover already in 2024

Nepa

Redeye believes Nepa is executing according to its plan to restore profitability. With cost savings exceeding the previously announced target and a market that appears to have bottomed out, Nepa is set to generate healthy cash flows already next year. Redeye estimates Nepa to be trading at an attractive 5x FCF multiple for 2024e, and 4x for 2025e. Also, with a new, still unknown 14%-stake shareholder, Redeye speculates in a possible bid on Nepa. Redeye raises its estimates and its valuation range.

Read more and download the Research Update.

Follow companies at Redeye to receive the latest equity research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/

Attachments


Nepa - Set to recover already in 2024

Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.